302 related articles for article (PubMed ID: 36839947)
1. Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses.
Pelusi L; Mandatori D; Mastropasqua L; Agnifili L; Allegretti M; Nubile M; Pandolfi A
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839947
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
[TBL] [Abstract][Full Text] [Related]
3. Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses.
Ribeiro AM; Figueiras A; Veiga F
J Pharm Pharm Sci; 2015; 18(5):683-95. PubMed ID: 26670365
[TBL] [Abstract][Full Text] [Related]
4. Topical ocular drug delivery systems: Innovations for an unmet need.
Yang Y; Lockwood A
Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
[TBL] [Abstract][Full Text] [Related]
5. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
6. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
Rathod LV; Kapadia R; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
8. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
9. Current nanotechnological strategies for treating glaucoma.
Goyal G; Garg T; Rath G; Goyal AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(5):365-405. PubMed ID: 25271557
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Laden Contact Lens for Controlled Ocular Delivery of Prednisolone: Formulation Optimization Using Statistical Experimental Design.
ElShaer A; Mustafa S; Kasar M; Thapa S; Ghatora B; Alany RG
Pharmaceutics; 2016 Apr; 8(2):. PubMed ID: 27104555
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
12. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Ophthalmic Lenses: A Review.
Toffoletto N; Saramago B; Serro AP
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33379411
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Potential of Nanoporous Materials for Advancing Ophthalmic Treatments.
Wu KY; Brister D; Bélanger P; Tran SD
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958583
[TBL] [Abstract][Full Text] [Related]
15. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
16. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
17. Contact lens as an emerging platform for ophthalmic drug delivery: A systematic review.
Yang H; Zhao M; Xing D; Zhang J; Fang T; Zhang F; Nie Z; Liu Y; Yang L; Li J; Wang D
Asian J Pharm Sci; 2023 Sep; 18(5):100847. PubMed ID: 37915758
[TBL] [Abstract][Full Text] [Related]
18. Novel Approaches in Formulation and Drug Delivery using Contact Lenses.
Singh K; Nair AB; Kumar A; Kumria R
J Basic Clin Pharm; 2011 Mar; 2(2):87-101. PubMed ID: 24826007
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
[TBL] [Abstract][Full Text] [Related]
20. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
